NLM Logo

Neostigmine MeSH Descriptor Data 2022


MeSH Heading
Neostigmine
Tree Number(s)
D02.092.877.674.666
D02.675.276.602
Unique ID
D009388
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D009388
Scope Note
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
Entry Term(s)
Neostigmine Bromide
Neostigmine Methylsulfate
Polstigmine
Proserine
Prostigmin
Prostigmine
Prozerin
Synstigmin
Syntostigmine
Pharm Action
Cholinesterase Inhibitors
Parasympathomimetics
Registry Number
3982TWQ96G
Related Numbers
005SYP50G5
114-80-7
51-60-5
59-99-4
98IMH7M386
CAS Type 1 Name
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-
NLM Classification #
QV 124
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2013/07/08
Neostigmine Preferred
Polstigmine Narrower
Neostigmine Bromide Narrower
Syntostigmine Narrower
Neostigmine Methylsulfate Narrower
Prostigmine Narrower
page delivered in 0.173s